破发股南模生物跌6.73% 2021年上市即巅峰募16.5亿元

Core Points - Nanmo Bio (688265.SH) closed at 56.09 yuan, with a decline of 6.73%, resulting in a total market capitalization of 4.373 billion yuan [1] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 28, 2021, with an initial stock issuance of 19.49 million shares at a price of 84.62 yuan per share [1][2] - The stock reached an intraday high of 82.00 yuan on its first trading day, but is currently in a state of decline [2] Fundraising and Financials - Nanmo Bio raised a total of 1.649 billion yuan through its initial public offering (IPO), with a net amount of 1.468 billion yuan after deducting issuance costs [2] - The net fundraising amount exceeded the original plan by 1.068 billion yuan, as the company initially aimed to raise 400 million yuan for various projects [2] - The total issuance costs for the IPO amounted to 181 million yuan, with underwriting and sponsorship fees accounting for 158 million yuan [3]